Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.72
1.98
NAV
₹31.03
₹430.43
Fund Started
20 Jun 2019
04 Jun 1999
Fund Size
₹858.87 Cr
₹4063.64 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
3.95%
3.54%
3 Year
22.41%
24.16%
5 Year
12.25%
15.34%
Equity
97.65%
98.16%
Cash
2.35%
1.77%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.42% |
Apollo Hospitals Enterprise Ltd. | 7.34% |
Torrent Pharmaceuticals Ltd. | 5.03% |
JB Chemicals & Pharmaceuticals Ltd. | 4.99% |
Aurobindo Pharma Ltd. | 4.42% |
Ajanta Pharma Ltd. | 4.22% |
Lupin Ltd. | 4.21% |
Ipca Laboratories Ltd. | 4.11% |
Abbott India Ltd. | 3.90% |
Fortis Healthcare Ltd. | 3.49% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Divi's Laboratories Ltd. | 6.59% |
Acutaas Chemicals Ltd. | 5.67% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Max Healthcare Institute Ltd. | 4.97% |
Lupin Ltd. | 4.10% |
Aster DM Healthcare Ltd. | 3.96% |
Torrent Pharmaceuticals Ltd. | 3.74% |
Aether Industries Ltd. | 3.56% |
Biocon Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
20 Jun 2019
04 Jun 1999
